Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Barrett Esophagus 3Zollinger-Ellison Syndrome 2Stomach Ulcer 1Neoplasms 1Multiple Endocrine Neoplasia Type 1 1Lymphoma 1Hot Flashes 1Esophagitis, Peptic 1Breast Neoplasms 1Advanced Non-small Cell Lung Cancer 1

Interventions

Esomeprazole 2YF 476 1Omeprazole 1Lansoprazole 1Dexlansoprazole 1Clopidogrel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Zollinger-Ellison Syndrome × Esomeprazole × Clear all
NCT00942175 2012-02-03

A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.

Takeda

Phase 1 Completed
160 enrolled 16 charts
Gastrointestinal

Esophagitis, Peptic, Stomach Ulcer, Zollinger-Ellison Syndrome

NCT00079833 2010-11-19

Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome

AstraZeneca

Phase 3 Completed
25 enrolled

Zollinger-Ellison Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡